Biktarvy, formally known as bictegravir, is a potent single-tablet therapy for managing HIV infection. This drug integrates three essential antiviral components: bictegravir, emtricitabine, and tenofovir alafenamide. It operates by inhibiting the HIV's ability to copy within the body, considerably reducing the viral quantity. For many individuals